JENNIFER DORCHUCK: Open Payments
NPI 1043641764 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 57 payments from 19 companies in 2025. Trend: 2023 $1,617 · 2024 $1,148 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $245 |
| Novo Nordisk Inc | 9 | $182 |
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| Lilly USA, LLC | 8 | $112 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| ViiV Healthcare Company | 2 | $50 |
| Verity Pharmaceuticals Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: VRAYLAR, Ozempic, BREZTRI, QULIPTA, JARDIANCE, MOUNJARO, Auvelity, SHINGRIX.
Industry payments across TX — which companies pay providers there.
